2017
Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy
Tan W, Lamb B, Khetrapal P, Tan M, Tan M, Sridhar A, Cervi E, Rodney S, Busuttil G, Nathan S, Hines J, Shaw G, Mohammed A, Baker H, Briggs T, Klein A, Richards T, Kelly J. Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy. Journal Of Endourology 2017, 31: 141-148. PMID: 27901350, DOI: 10.1089/end.2016.0730.Peer-Reviewed Original ResearchMeSH KeywordsAdultAgedAnemiaBlood Loss, SurgicalBlood TransfusionCystectomyFemaleHumansMaleMiddle AgedNeoadjuvant TherapyPerioperative PeriodPostoperative ComplicationsPreoperative PeriodPrevalenceProspective StudiesRobotic Surgical ProceduresTransfusion ReactionUrinary Bladder NeoplasmsUrinary DiversionConceptsBlood transfusion requirementsAssociated with perioperative morbidityPreoperative anemiaTransfusion requirementsBlood transfusionComplication ratePerioperative morbidityAssociated with increased surgical riskPresence of preoperative anemiaPrevalence of preoperative anemiaAssociated with increased perioperative morbidityAssociated with perioperative complicationsImpact of preoperative anemiaAssociated with increased complicationsPostoperative blood transfusion rateLower lymph node yieldPostoperative blood transfusion requirementsRobot-assisted radical cystectomyPreoperatively anemic patientsIntraoperative blood transfusionLymph node yieldPostoperative blood transfusionBlood transfusion rateClavien-Dindo systemHospital length of stay
2014
Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice
Tan W, Lamb B, Payne H, Hughes S, Green J, Lane T, Adshead J, Boustead G, Vasdev N. Management of Node-Positive Bladder Cancer After Neoadjuvant Chemotherapy and Radical Cystectomy: A Survey of Current UK Practice. Clinical Genitourinary Cancer 2014, 13: e153-e158. PMID: 25510376, DOI: 10.1016/j.clgc.2014.11.006.Peer-Reviewed Original ResearchConceptsNeoadjuvant chemotherapy regimenNeoadjuvant chemotherapyPositive lymph nodesRadical cystectomyAdjuvant chemotherapyTreatment of patientsBladder cancerNodal diseaseLymph nodesIndication of adjuvant chemotherapyNode-positive bladder cancerPresence of disease progressionResponse to NACCancer CenterMuscle-invasive bladder cancerCycles of gemcitabineAdvanced bladder cancerPatient performance statusUro-oncologistsChemotherapy regimenPerformance statusLack of published evidenceDisease progressionChemotherapyPatients